|
gptkbp:instance_of
|
gptkb:physicist
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Repatha
|
|
gptkbp:advocates_for
|
gptkb:FH_Foundation
gptkb:Heart_UK
gptkb:National_Lipid_Association
|
|
gptkbp:affects
|
cholesterol levels
|
|
gptkbp:associated_with
|
gptkb:xanthomas
atherosclerosis
coronary artery disease
tendon xanthomas
|
|
gptkbp:caused_by
|
LDLR gene mutation
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:complications
|
gptkb:peripheral_artery_disease
heart attack
stroke
|
|
gptkbp:descendant
|
autosomal dominant
|
|
gptkbp:first_described_by
|
gptkb:Dr._William_Oliver
1930s
|
|
gptkbp:guidance_system
|
gptkb:European_Society_of_Cardiology
gptkb:healthcare_organization
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
familial hypercholesterolemia
|
|
gptkbp:is_a_resource_for
|
support groups
online forums
videos
webinars
brochures
|
|
gptkbp:is_popular_in
|
1 in 200 to 1 in 500 people
|
|
gptkbp:is_tested_for
|
gptkb:battle
|
|
gptkbp:manager
|
regular cholesterol monitoring
|
|
gptkbp:public_awareness
|
gptkb:battle
|
|
gptkbp:research_focus
|
gptkb:physicist
new medications
|
|
gptkbp:risk_factor
|
obesity
family history
smoking
sedentary lifestyle
high-fat diet
|
|
gptkbp:screenings
|
family members of affected individuals
|
|
gptkbp:social_responsibility
|
lipid panel
|
|
gptkbp:symptoms
|
high LDL cholesterol
premature cardiovascular disease
|
|
gptkbp:treatment
|
lifestyle changes
statins
PCS K9 inhibitors
LDL apheresis
|